News & Publications

WHITE PAPER: Operational Analysis for Treatment With Psychedelic-Assisted Psychotherapy

ARTICLE: The Impact of Reinsurance of Gene Therapies on Employer Financial Risk

PODCAST: Decoding HEOR: Iris Tam’s Insights on Pharma’s Value-Based Future

ARTICLE: Value-Based Contracts Provide Options for State Medicaid Programs to Cover Gene Therapies

FDA Commissioner’s National Priority Voucher Program

The Growing Need for Specialty Drug Manufacturers to Take Notice of Self-Funded Employer Trends

Access Deployment Solutions

FDA Commissioner’s National Priority Voucher Program

Four Medicaid Proposals That May Cut Enrollment—and Manufacturer Revenues

Unlocking the Power of Value-Based Contracts: Applying Operational Lessons from Gene Therapy to Broader Therapeutic Markets

Performance Guarantees: Leveraging Technology to Enable Insights Into Reimbursement Opportunities

Weighing the Costs and Benefits of GLP-1 Drugs: A Case for Aligning Value with Outcomes

Aligning Oncology Drug Prices With Value: The Case for Innovative Pricing Models

Market Access and Field Force Design

AMP Cap Repeal

Accelerating the Transition to Value in Value-Based Contracting

Choosing the Right Operational Vendors

Feb 4, 2025

Red Nucleus Announces Acquisition of COEUS